BioSpace News Archive

FDA

Admetsys’ FDA Breakthrough Designation Accelerates Arrival of Fully Autonomous Clinical Robotics in Hospital

Admetsys Corporation, a biomedical technology company specializing in critical care automation, announced today that the FDA has designated its automated glucose control and continuous blood diagnostics system a Breakthrough Device.

September 6, 2023

·

2 min read

BioMidwest

Heart Centre Rigshospitalet Enhances Leadership in Patient Care with Adoption of Latest Robotic Technology

Stereotaxis announced that physicians at Heart Centre Rigshospitalet of Copenhagen University Hospital successfully treated the first patients using Stereotaxis’ Genesis Robotic Magnetic Navigation System.

September 6, 2023

·

4 min read

Biotech Beach

Join BOTOX® Cosmetic (onabotulinumtoxinA) and IFundWomen in Supporting Women Entrepreneurs

Allergan Aesthetics, an AbbVie company (NYSE: ABBV) today announced the next chapter of the BOTOX® Cosmetic and IFundWomen grant program with the launch of crowdfunding campaigns for the women entrepreneurs.

September 6, 2023

·

7 min read

Altamira Therapeutics to Host First Half 2023 Financial Results and Business Update Call on September 12th

Altamira Therapeutics Ltd. announced that it will host its First Half of 2023 Financial Results and Business Update Call on Tuesday, September 12, 2023.

September 6, 2023

·

4 min read

PharmAla Begins Trading on OTCQB

PharmAla Biotech Holdings Inc. is pleased to announce that it has qualified for trading on the OTCQB Venture Market in the United States operated by the OTC Markets Group Inc. and the Company’s common shares commenced trading on the OTCQB under the symbol “PMBHF”.

September 6, 2023

·

4 min read

Biotech Beach

Artelo Biosciences to Present at the 6th Cannabinoid-Derived Drug Development Summit on September 12th

Artelo Biosciences, Inc. (Nasdaq: ARTL) Medicinal Chemist at Artelo Biosciences, will be presenting at the 6th Cannabinoid-Derived Drug Development Summit being held September 11-13, 2023 at the Hilton Boston Back Bay hotel in Boston, MA.

September 6, 2023

·

3 min read

Business

IMIDomics Inc. Secures Exclusive Worldwide Licensing Agreement with TNAX Biopharma Corporation for TNAX101A (IMB1001), A Promising Drug Candidate for Immune-Mediated Inflammatory Diseases

IMIDomics Inc., a patient-centric drug discovery and development company focused on Immune-Mediated Inflammatory Diseases (IMIDs), today announced an exclusive license agreement with TNAX Biopharma Corporation (TNAX), an innovator in biotechnology.

September 6, 2023

·

5 min read

BioForest

Gilead Sciences: How One School Has Transformed Education for First-Generation Students

As an elementary school student, Nohely Peraza took a bus from her home in East Palo Alto to a school several miles away in another city.

September 6, 2023

·

4 min read

Policy

Telo Genomics Achieves Noteworthy International Standards Organization (“ISO”) Regulatory Accreditation

Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the “Company” or “Telo”) is proud to announce that it has successfully completed the final assessment and achieved ISO 15189 accreditation. ISO 15189 is the international standard specific for clinical laboratories.

September 6, 2023

·

4 min read

Drug Development

Awakn Life Sciences Submits Clinical Trial Application for Phase III Trial of AWKN-P001

AWKN-P001 is a N-methyl-D-aspartate Receptor-Modulating Drug Used in Combination with Psycho-Social Support for the Treatment of Severe Alcohol Use Disorder

September 6, 2023

·

7 min read